Sudden cardiac death in pediatrics

Current Opinion in Pediatrics

Volumn 20, Issue 5, 2008, Pages 517-521

  Bar Cohen, Yaniv ^a   Silka, Michael J ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b Mail Stop #34 ^*  (United States)

Author keywords

Cardiomyopathy; Congenital heart disease; Genetics; Sudden cardiac death

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL; SODIUM CHANNEL; SOTALOL; VERAPAMIL;

ABSENCE OF SIDE EFFECTS; ATHLETE; AUTOPSY; BRUGADA SYNDROME; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CATHETER ABLATION; CONGENITAL HEART DISEASE; DEFIBRILLATOR; EXERCISE; GENETIC DISORDER; HEART ARRHYTHMIA; HEART TRANSPLANTATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; LONG QT SYNDROME; MEDICAL RESEARCH; MUSCLE RESECTION; MUTATION; PATIENT CARE; PEDIATRICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; RISK FACTOR; RISK REDUCTION; SCHOOL; SCREENING; SICK SINUS SYNDROME; SIDE EFFECT; SUDDEN DEATH; SUDDEN INFANT DEATH SYNDROME; SYNCOPE; TREATMENT PLANNING;

ADOLESCENT; AGE DISTRIBUTION; ATRIAL FIBRILLATION; CARDIOMYOPATHY, DILATED; CARDIOVASCULAR DISEASES; CATHETER ABLATION; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INFANT, NEWBORN; MALE; PEDIATRICS; PREVALENCE; PROGNOSIS; RISK FACTORS; SEX DISTRIBUTION; SUDDEN INFANT DEATH;

EID: 53649110774     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32830c9037     Document Type: Review

References (32)

1. Lehnart SE, Ackerman MJ, Benson DW Jr, et al. Inherited arrhythmias: a National Heart, Lung, and Blood Institute and Office of Rare Diseases workshop consensus report about the diagnosis, phenotyping, molecular mechanisms, and therapeutic approaches for primary cardiomyopathies of gene mutations affecting ion channel function. Circulation 2007; 116:2325-2345.
2. Probst V, Denjoy I, Meregalli PG, et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007; 115:2042-2048.
3. Saenen JB, Vrints CJ. Molecular aspects of the congenital and acquired long QT syndrome: clinical implications. J Mol Cell Cardiol 2008; 44:633-646.
4. Moss AJ, Shimizu W, Wilde AA, et al. Clinical aspects of type-1 long-QT syndrome by location, coding type, and biophysical function of mutations involving the KCNQ1 gene. Circulation 2007; 115:2481-2489.
5. Taggart NW, Haglund CM, Tester DJ, Ackerman MJ. Diagnostic miscues in congenital long-QT syndrome. Circulation 2007; 115:2613-2620.
6. Etheridge SP, Sanatani S, Cohen Ml, et al. Long QT syndrome in children in the era of implantable defibrillators. J Am Coll Cardiol 2007; 50:1335-1340.
7. Schwartz PJ, Spazzolini C, Crotti L, et al. The Jervell and Lange-Nielsen syndrome: natural history, molecular basis, and clinical outcome. Circulation 2006; 113:783-790.
8. Hobbs JB, Peterson DR, Moss AJ, et al. Risk of aborted cardiac arrest or sudden cardiac death during adolescence in the long-QT syndrome. JAMA 2006; 296:1249-1254.
9. Napolitano C, Priori SG. Diagnosis and treatment of catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007; 4:675-678.
10. Sumitomo N, Sakurada H, Taniguchi K, et al. Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia. Circ J 2007; 71:1606-1609.
11. Rosso R, Kaiman JM, Rogowski O, et at. Calcium channel blockers and beta-blockers versus beta-blockers alone for preventing exercise-induced arrhythmias in catecholaminergic polymorphic ventricular tachycardia. Heart Rhythm 2007; 4:1149-1154.
12. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death - executive summary: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. J Am Coll Cardiol 2006; 48:1064-1108.
13. Wang DW, Desai RR, Crotti L, et al. Cardiac sodium channel dysfunction in sudden infant death syndrome. Circulation 2007; 115:368-376.
14. Arnestad M, Crotti L, Rognum TO, et al. Prevalence of long-QT syndrome gene variants in sudden infant death syndrome. Circulation 2007; 115:361-367.
15. Tan HL, Hofman N, van Langen IM, et al. Sudden unexplained death: heritability and diagnostic yield of cardiological and genetic examination in surviving relatives. Circulation 2005; 112:207-213.
16. Hofman N, Tan HL, Clur SA, et al. Contribution of inherited heart disease to sudden cardiac death in childhood. Pediatrics 2007; 120:e967-e973.
17. Tester DJ, Ackerman MJ. Postmortem long QT syndrome genetic testing for sudden unexplained death in the young. J Am Coll Cardiol 2007; 49:240-246. Molecular autopsy is proposed for cases of otherwise unexplained sudden death in young patients with no known heart disease.
18. Nieminen HP, Jokinen EV, Sairanen HI. Causes of late deaths after pediatric cardiac surgery: a population-based study. J Am Coll Cardiol 2007; 50:1263-1271.
19. Khairy P, Harris L, Landzberg MJ, et al. Implantable cardioverter-defibrillators in tetralogy of Fallot. Circulation 2008; 117:363-370.
20. Kriebel T, Saul JP, Schneider H, et al. Noncontact mapping and radiofre-quency catheter ablation of fast and hemodynamically unstable ventricular tachycardia after surgical repair of tetralogy of Fallot. J Am Coll Cardiol 2007; 50:2162-2168.
21. Zeppenfeld K, Schalij MJ, Bartelings MM, et al. Catheter ablation of ventricular tachycardia after repair of congenital heart disease: electroanatomic identification of the critical right ventricular isthmus. Circulation 2007; 116:2241-2252.
22. Bongioanni S, Bianchi F, Migliardi A, et al. Relation of QRS duration to mortality in a community-based cohort with hypertrophic cardiomyopathy. Am J Cardiol 2007; 100:503-506.
23. Ommen SR, Maron BJ, Olivotto I, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 2005; 46:470-476.
24. McLeod CJ, Ommen SR, Ackerman MJ, et al. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy. Eur Heart J 2007; 28: 2583-2588.
25. Melacini P, Maron BJ, Bobbo F, et al. Evidence that pharmacological strategies lack efficacy for the prevention of sudden death in hypertrophic cardiomyopathy. Heart 2007; 93:708-710.
26. Rhee EK, Canter CE, Basile S, et al. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome? J Heart Lung Transplant 2007; 26:447-452.
27. Hayashi T, Tsuda E, Kurosaki K, et al. Electrocardiographic and clinical characteristics of idiopathic restrictive cardiomyopathy in children. Circ J 2007; 71:1534-1539.
28. Maron BJ, Thompson PD, Ackerman MJ, et al. American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Recommendations and considerations related to preparticipation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council on Nutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007; 115:1643-1655.
29. Pelliccia A, Fagard R, Bjørnstad HH, et al., Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology; Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005; 26:1422-1445.
30. Bille K, Schamasch P, Brenner Jl, et al. Sudden deaths in athletes: the basics of the 'Lausanne Recommendations' of the International Olympic Committee. Circulation 2005; 112 (suppl II):II-830.
31. Chaitman BR. An electrocardiogram should not be included in routine preparticipation screening of young athletes. Circulation 2007; 116:2610-2614.
32. Myerburg RJ, Vetter VL. Electrocardiograms should be included in preparticipation screening of athletes. Circulation 2007; 116:2616-2626.